| Scent dog identification of samples from COVID-19 patients–a pilot study P Jendrny, C Schulz, F Twele, S Meller, M von Köckritz-Blickwede, ... BMC infectious diseases 20, 1-7, 2020 | 209 | 2020 |
| Significant effects of sex, strain, and anesthesia in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy F Twele, K Töllner, C Brandt, W Löscher Epilepsy & Behavior 55, 47-56, 2016 | 65 | 2016 |
| The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy F Twele, M Bankstahl, S Klein, K Römermann, W Löscher Neuropharmacology 95, 234-242, 2015 | 62 | 2015 |
| Consequences of inhibition of bumetanide metabolism in rodents on brain penetration and effects of bumetanide in chronic models of epilepsy M Töpfer, K Töllner, C Brandt, F Twele, S Bröer, W Löscher European Journal of Neuroscience 39 (4), 673-687, 2014 | 56 | 2014 |
| The bumetanide prodrug BUM 5, but not bumetanide, potentiates the antiseizure effect of phenobarbital in adult epileptic mice T Erker, C Brandt, K Töllner, P Schreppel, F Twele, A Schidlitzki, ... Epilepsia 57 (5), 698-705, 2016 | 53 | 2016 |
| The intrahippocampal kainate mouse model of mesial temporal lobe epilepsy: Lack of electrographic seizure‐like events in sham controls F Twele, A Schidlitzki, K Töllner, W Löscher Epilepsia Open 2 (2), 180-187, 2017 | 43 | 2017 |
| Canine olfactory detection and its relevance to medical detection P Jendrny, F Twele, S Meller, ADME Osterhaus, E Schalke, HA Volk BMC infectious diseases 21, 1-15, 2021 | 39 | 2021 |
| A combination of NMDA and AMPA receptor antagonists retards granule cell dispersion and epileptogenesis in a model of acquired epilepsy A Schidlitzki, F Twele, R Klee, I Waltl, K Römermann, S Bröer, S Meller, ... Scientific Reports 7 (1), 12191, 2017 | 39 | 2017 |
| The effects of carbamazepine in the intrahippocampal kainate model of temporal lobe epilepsy depend on seizure definition and mouse strain F Twele, K Töllner, M Bankstahl, W Löscher Epilepsia Open 1 (1-2), 45-60, 2016 | 38 | 2016 |
| Scent dog identification of SARS-CoV-2 infections in different body fluids P Jendrny, F Twele, S Meller, C Schulz, M von Köckritz-Blickwede, ... BMC Infectious Diseases 21, 1-14, 2021 | 36 | 2021 |
| Disruption of the sodium-dependent citrate transporter SLC13A5 in mice causes alterations in brain citrate levels and neuronal network excitability in the hippocampus C Henke, K Töllner, RM van Dijk, N Miljanovic, T Cordes, F Twele, S Bröer, ... Neurobiology of Disease 143, 105018, 2020 | 33 | 2020 |
| A face‐to‐face comparison of the intra‐amygdala and intrahippocampal kainate mouse models of mesial temporal lobe epilepsy and their utility for testing novel therapies L Welzel, A Schidlitzki, F Twele, M Anjum, W Löscher Epilepsia 61 (1), 157-170, 2020 | 33 | 2020 |
| The novel antiepileptic drug imepitoin compares favourably to other GABA-mimetic drugs in a seizure threshold model in mice and dogs W Löscher, K Hoffmann, F Twele, H Potschka, K Töllner Pharmacological Research 77, 39-46, 2013 | 33 | 2013 |
| Proof-of-concept that network pharmacology is effective to modify development of acquired temporal lobe epilepsy A Schidlitzki, P Bascuñana, PK Srivastava, L Welzel, F Twele, K Töllner, ... Neurobiology of Disease 134, 104664, 2020 | 27 | 2020 |
| Discrimination of SARS-CoV-2 infections from other viral respiratory infections by scent detection dogs NA Ten Hagen, F Twele, S Meller, P Jendrny, C Schulz, ... Frontiers in medicine 8, 749588, 2021 | 23 | 2021 |
| Network pharmacology for antiepileptogenesis: tolerability and neuroprotective effects of novel multitargeted combination treatments in nonepileptic vs. post-status epilepticus … L Welzel, F Twele, A Schidlitzki, K Töllner, P Klein, W Löscher Epilepsy research 151, 48-66, 2019 | 18 | 2019 |
| Selective inhibition of mTORC1/2 or PI3K/mTORC1/2 signaling does not prevent or modify epilepsy in the intrahippocampal kainate mouse model B Gericke, C Brandt, W Theilmann, L Welzel, A Schidlitzki, F Twele, ... Neuropharmacology 162, 107817, 2020 | 17 | 2020 |
| Evaluation of the pentylenetetrazole seizure threshold test in epileptic mice as surrogate model for drug testing against pharmacoresistant seizures K Töllner, F Twele, W Löscher Epilepsy & Behavior 57, 95-104, 2016 | 17 | 2016 |
| Systematic evaluation of rationally chosen multitargeted drug combinations: a combination of low doses of levetiracetam, atorvastatin and ceftriaxone exerts antiepileptogenic … L Welzel, DH Bergin, A Schidlitzki, F Twele, M Johne, P Klein, W Löscher Neurobiology of Disease 149, 105227, 2021 | 14 | 2021 |
| Expert considerations and consensus for using dogs to detect human SARS-CoV-2-infections S Meller, MSA Al Khatri, HK Alhammadi, G Álvarez, G Alvergnat, LC Alves, ... Frontiers in medicine 9, 1015620, 2022 | 10 | 2022 |
Sebastian MellerResearch Associate, Department of Small Animal Medicine & Surgery, University of Veterinary MedicineVerified email at tiho-hannover.de
